FDA 483 - Roberto Salvatori, M.D. - May 13, 2021

An FDA inspection of Roberto Salvatori, M.D. in Baltimore, MD, revealed significant deficiencies in maintaining accurate case histories for clinical investigations. The firm failed to report adverse events and concomitant medications in electronic data capture for multiple studies. These findings indicate serious issues with data integrity and record-keeping practices during clinical trials.